← PT-141 overview

PT-141 Dosage & Reconstitution Guide

Research and educational use only — not medical advice, and not for human consumption. The figures below are summarized from public sources, product labeling, and community reports, and are not a prescription or a substitute for a qualified clinician.

Typical dose
1.75 mg
Route
Subcutaneous injection
Frequency
as needed — not a daily peptide
After mixing
5 mg/mL (5000 mcg/mL)

Reconstitution

PT-141 ships as a freeze-dried (lyophilized) powder that has to be mixed with bacteriostatic water before use. Draw 2 mL of bacteriostatic water into a syringe and add it to a 10 mg vial, letting the stream run down the inside wall of the glass rather than blasting the powder directly. Swirl gently — never shake — until the solution is clear, then keep it refrigerated.

Worked example. 2 mL into a 10 mg vial gives a concentration of 5 mg/mL (5000 mcg/mL). A 1.75 mg dose then works out to 0.35 mL = 35 units on a U-100 insulin syringe. Scale the water volume up or down to make your target dose land on an easy-to-read mark (1 unit = 0.01 mL).

  1. Wipe both vial stoppers (peptide and bacteriostatic water) with an alcohol swab and let them dry.
  2. Draw 2 mL of bacteriostatic water into a syringe.
  3. Inject it slowly against the inside wall of the peptide vial.
  4. Swirl gently until fully dissolved; do not shake.
  5. Label the vial with the contents, concentration, and date, and store it in the refrigerator.

Dosing schedule

Phase Dose Volume Insulin units (U-100) Notes
First trial 0.5 mg 0.1 mL 10 units tolerance check
If needed 1 mg 0.2 mL 20 units single dose
Standard (label) 1.75 mg 0.35 mL 35 units single dose

Timing & cycling

Inject about 45 minutes to 1 hour before intended activity. Effects can last through the evening; some report a window into the next day.

Cycle length. On-demand only. Approved labeling: no more than one dose per 24 hours and no more than 8 doses per month.

Storage & handling

Keep the lyophilized (unmixed) vial refrigerated at 2–8 °C (36–46 °F) in a dry, dark place — it tolerates short periods at room temperature during shipping. Once reconstituted, store it at 2–8 °C, never frozen, and use it within about 2–4 weeks (sooner if the solution turns cloudy or discolored). Swab the stopper before every draw and use a fresh needle each time.

Supplies you'll need

  • PT-141 vials — about 2 for an 8-week run at the upper dose
  • Bacteriostatic water — 2 mL per vial (a 10–30 mL multi-dose bottle covers several vials)
  • U-100 insulin syringes (0.3–0.5 mL / 30–50 unit barrels are easiest to read) — roughly 8 for 8 weeks, plus spares
  • Alcohol swabs — one per injection and one per vial draw
  • Sharps container for safe needle disposal

Key points

  • Nausea hits roughly 40% at the label dose — the reason to trial 0.5–1 mg first. An anti-nausea plan is not overkill.
  • Skin flushing and temporary darkening around the injection site are common.
  • Works on melanocortin receptors in the brain, not on blood flow — it does not replace PDE5 drugs, and combining warrants caution on BP.

What to monitor

Blood pressure — bremelanotide transiently raises BP and is contraindicated with uncontrolled hypertension or cardiovascular disease.

Legal & prescription status

Yes. This is an FDA-approved prescription medication (bremelanotide (brand Vyleesi)), so a legitimate, human-grade version is available only through a licensed prescriber and pharmacy. The lookalike 'research chemical' versions sold online are unapproved, not quality-controlled, and labelled 'not for human consumption.'

References

  1. ncbi.nlm.nih.gov
  2. ncbi.nlm.nih.gov
  3. ncbi.nlm.nih.gov

This guide is for research and educational purposes only. It is not medical advice and does not describe a product approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.